Contact
Please use this form to send email to PR contact of this press release:
FTC Requires Sale of Generic Cancer Pain Drug and Muscle Relaxant as Conditions of Tevas $6.8 Billion Acquisition of Cephalon
TO:
Please use this form to send email to PR contact of this press release:
FTC Requires Sale of Generic Cancer Pain Drug and Muscle Relaxant as Conditions of Tevas $6.8 Billion Acquisition of Cephalon
TO: